Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People 2019-11-17 12:00
Viva Biotech Partnership Summit Successfully Launched in Shanghai 2019-11-15 14:16
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China 2019-11-14 23:45
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
MeMed Wins €2.5M Award from European Innovation Council 2019-11-14 09:00
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
Merck Licenses CRISPR Gene-Editing Technology to Evotec 2019-11-12 21:00
ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders 2019-11-11 21:45
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Akeso, Inc. Completes Series-D Private Financing for US$150 Million 2019-11-09 00:43
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company 2019-11-08 21:24
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial 2019-11-08 21:00
SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe 2019-11-08 17:36
Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes 2019-11-08 11:00
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 21:02
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million 2019-11-07 19:04
Bactiguard Holding AB (publ): Interim Report for Q3 2019 2019-11-07 15:23
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma 2019-11-07 11:02
1 301 302 303 304 305 401